Quotes Decoy Therapeutics Inc. London S.E.

Stocks

End-of-day quote London S.E.			5-day change	1st Jan Change
- ^GBX	-.--%		-.--%	-

08-12	Decoy Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-27	Decoy Therapeutics Demonstrates In Vitro Activity Of D-MAV Candidate Against Wild-Type Ebola Zaire Virus And Opens Exploratory Program To Design D-MAVs Against Filoviruses Including Ebola And Marburg	CI

Stock exchange

London S.E.- p -.--% 0 p

Markets		Price	Change	Volumes
Nasdaq	DCOY	2.710USD	0.00%	394K $
CBOE	DCOY	2.720USD	+1.87%	34.27K $

markets

Capital turnover ratio

Float rotation

Market Cap (GBX)

1,775,551

Market Cap (USD)

1,775,551

Net sales (USD)

Number of employees

Sales / Employee (USD)

Free-Float

89.57%

Free-Float capitalization (GBX)

1,590,279

Free-Float capitalization (USD)

1,590,279

RSI 9 days

RSI 14 days

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DECOY THERAPEUTICS INC.	-.--%	-.--%	-	-	1.78M
WUXI APPTEC CO., LTD.	-1.38%	+0.20%	+46.42%	+96.33%	70.24B
ARGENX SE	-1.04%	-0.81%	+34.61%	+75.16%	62.63B
INSMED INCORPORATED	-4.29%	-3.98%	-16.22%	+350.66%	27.36B
WUXI BIOLOGICS (CAYMAN) INC.	+0.16%	-0.16%	+26.73%	+12.12%	25.71B
BIONTECH SE	-2.20%	-2.00%	-1.22%	-14.48%	24.83B
GENMAB A/S	+1.61%	-0.69%	+20.85%	-19.42%	19.52B
PHARMAESSENTIA CORPORATION	+1.26%	-14.23%	+170.04%	+298.75%	15.51B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-3.91%	-5.25%	-9.16%	+485.32%	14.66B
SUMMIT THERAPEUTICS INC.	-5.54%	+0.69%	-8.13%	+830.48%	14.69B
Average	-1.53%	-2.20%	+29.32%	+234.99%	27.52B
Weighted average by Cap.	-1.52%	-1.32%	+30.64%	+162.07%